檢索結果 - Martin Lord
- Showing 1 - 2 results of 2
-
1
Preclinical development and clinical safety assessment of a fully synthetic peptide-peptide conjugate built to enable endogenous antibody binding, complex formation, and innate rec... 由 Erika Fletcher, Robert A. Cordfunke, Aikaterini Nasi, Gunilla Törnqvist, Rob Valentijn, Anna Bergqvist, Marita Westhrin, Wenche Rasch, Frida Lindqvist, Inken Dillmann, Martin Lord, Neanke Bouwman, Jacques Neefjes, Kees L. M. C. Franken, Stéphanie McArdle, Murrium Ahmad, Silvia Johansson, Ferry Ossendorp, Michael Häggman, Maria Lampinen, Gustav Ullenhag, Sam Ladjevardi, Justyna Leja-Jarblad, Wolfgang Lilleby, Jan W. Drijfhout, Sara M. Mangsbo
出版 2025Artigo -
2
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19 由 Sebastian Havervall, Henry Ng, August Jernbom Falk, Nina Greilert‐Norin, Anna Månberg, Ulrika Marking, Ida Laurén, Lena Gabrielsson, Ann‐Christin Salomonsson, Katherina Aguilera, Martha Kihlgren, Maja Månsson, Axel Rosell, Cecilia Hellström, Eni Andersson, Jennie Olofsson, Lovisa Skoglund, Jamil Yousef, Elisa Pin, Martin Lord, Mikael Åberg, My Hedhammar, Hanna Tegel, Pierre Dönnes, Mia Phillipson, Peter Nilsson, Jonas Klingström, Sara M. Mangsbo, Sophia Hober, Charlotte Thålin
出版 2021Artigo
相關主題
Immunology
Medicine
2019-20 coronavirus outbreak
Antibody
Asymptomatic
Biochemistry
Biology
Cellular immunity
Chemistry
Computational biology
Conjugate
Coronavirus disease 2019 (COVID-19)
Disease
Endogeny
Humoral immunity
Immune system
Infectious disease (medical specialty)
Internal medicine
Mathematical analysis
Mathematics
Outbreak
Peptide
Receptor
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Virology